HMOX1 and cancer: To evaluate KCL-HO-1i as an anti-cancer therapeutic for targeting PvTAMs in cancer we treated MMTV-PyMT mice bearing established tumors with KCL-HO-1i using i.p. delivery (to allow a side-by-side comparison with SnMP).